Cancer Research News: March 28 – April 11

Cancer deaths in the U.S. have declined from 1999 to 2008.
Cruciferous vegetable intake is associated with decreased mortality and recurrence in breast cancer patients.
Epigenetic changes in cells can indicate cancer risk.
A new genomic marker database, CancerRXGene.org , presents information on drug sensitivity and cancer cell lines.
A UCSF study found disparities in use of fertility preservation in young women with cancer.

Cancer Research News: March 14 – March 27

Researchers have discovered a way to disable a mechanism that prevents chemotherapy from reaching pancreatic cancer cells.
A gene that causes prostate cancer cells to increase growth may be a new target for therapy.
The 2012 National Conference on Health Statistics will be held August 6-8, 2012, in Washington DC.
Cervical cancer screening guidelines have been revised.
20^th century tobacco control programs and policies were responsible for preventing more than 795,000 lung cancer deaths in the United States from 1975 through 2000.

Combination therapy may increase Gemcitabine levels for pancreatic cancer.
Targeted therapy Vemurafenib improves survival in patients with metastatic melanoma.
Chemotherapy can lead to cognitive deficits more than 20 years later.
NEJM reports that tumor heterogeneity may complicate personalized medicine when targeting genes.
Combined inhibition of VEGF and c-MET can slow tumor growth.
Circumcision is associated with a reduction in risk of prostate cancer.